Mail: Fwd: FW: Zandra POA

---------- Forwarded message ----------
From: Rakhi Sharma [Pharma] <rakhi.sharma@himalayahealthcare.com>
Date: Mon, Dec 21, 2009 at 3:57 PM
Subject: FW: Zandra POA
To: "shyam.sudhindra@gmail.com" <shyam.sudhindra@gmail.com>
Cc: DesignTeam <designteam@himalayahealthcare.com>, "Sudheer S [Pharma]" <sudheer.s@himalayahealthcare.com>

Dear Mr.Kini/Mr.Shyam,

All the corrections are done except following :

Pg 7: In the table - Instead of Liv.52 group make it to read Liv.52 DS group (Value) Rs.

- last column instead of value, make it to read - YPRPM (Value) Rs.

Pg 8: In the table - instead of Evecare group, make it to read - Evecare group (Value) Rs.

- last column instead of value, make it to read - YPRPM (Value) Rs.

These corrections are to be carried out in the table. The heading should be same as before.

Please send the pdf of only these two pages, for approval.

Regds,

Rakhi Sharma,
Product Manager - Pharma (Zandra div)

The Himalaya Drug Company
Makali, Bangalore 562 123, India

T +91 80 371 4444 · F +91 80 371 4480
rakhi.sharma@himalayahealthcare.com

www.himalayahealthcare.com <<http://www.himalayahealthcare.com/>>

This message is intended only for the use of the individual or entity to which it is addressed and may contain information that is privileged, confidential and exempt from disclosure. If you are not the intended recipient, you are notified that any disclosure, copying, distribution or use of this communication is strictly prohibited. If you have erroneously received this message, please delete it immediately and notify the sender. Thank you.

From: Sudheer S [mailto:sudheersrinivas@gmail.com]
Sent: 19 December 2009 13:23
To: Shyamsunder sunder
Cc: DesignTeam; Rakhi Sharma [Pharma]
Subject: Re: Zandra POA

Dear Mr.Kini/Mr.Shyam,

Please make the following corrections in the pdf sent by you. Please make the required changes and send the final pdf file for approval.

Please do the needful,

Pg 3: Contents - Oxitard launching POA should change to Oxitard launch details

Pg 4:Talkt Syrup 120 ml should change to Talekt Syrup 120 ml

Pg 5: after 70% add - achievement to the annual target to read as - >70% achievement to the annual target

Pg 7: In the table - Instead of Liv.52 group make it to read Liv.52 DS group (Value) Rs.

- last column instead of value, make it to read - YPRPM (Value) Rs.

Pg 8: In the table - instead of Evecare group, make it to read - Evecare group (Value) Rs.

- last column instead of value, make it to read - YPRPM (Value) Rs.

Pg9: in the promotional plan table, instead of chemist indent book, make it Chemist requirement book

Pg 11: Top 10 pharmaceutical manufacturers should change to Top 10 Pharmaceutical Companies

Pg 22: Doctor, you will agree with me that hormonal imbalance can disrupt her daily routine and can cause infertility should change to Doctor, you will agree with me that hormonal imbalance can cause infertility

Pg 29: The beacon of hope for diabetics with 4C advantage - Remove with 4C advantage

Pg 30: Diabecon DS scientific folder - Feb'10 make it as Diabecon DS scientific folder - Jan'10

Pg 43: The target set for you is 12 shippers - Make it The target set for you is 26 shippers

Pg 49: Tertiary packing: 50 such cartons in each shipper carton should change to 28 such cartons in each shipper carton

MRP - Each strip of 10 capsules costs Rs.90 should change to Each strip of 10 capsules costs Rs.30

Pg 50: In the competitor's section, Remove the entire row of Cobadex-CZS

Thanks and Regards,

Sudheer S

Group Product Manager-Pharmaceutical Division

The Himalaya Drug Company
Makali, Bangalore 562 123, India
T +91 80 2371 4444 · F +91 80 2371 4480

sudheer.s@himalayahealthcare.com www.himalayahealthcare.com
This message is intended only for the use of the individual or entity to which it is addressed and may contain information that is privileged, confidential and exempt from disclosure. If you are not the intended recipient, you are notified that any disclosure, copying, distribution or use of this communication is strictly prohibited. If you have erroneously received this message, please delete it immediately and notify the sender. Thank you.

On Sat, Dec 19, 2009 at 11:55 AM, Shyamsunder sunder <shyam.sudhindra@gmail.com> wrote:

---------- Forwarded message ----------
From: Kini <kinigk@gmail.com>
Date: Sat, Dec 19, 2009 at 10:49 AM
Subject: Zandra POA
To: designteam@himalayahealthcare.com
Cc: "Sudheer S [Pharma]" <sudheer.s@himalayahealthcare.com>, sudheersrinivas@gmail.com, Sham-Sudhindra <shyam.sudhindra@gmail.com>

Regards

Kini

127, Coconut Avenue Road, 8th Cross, Malleswaram, Bangalore 560 003

080-23342069 990 190 5354, 924 124 5433

P Please do not print this email unless it is absolutely necessary. Reduce. Reuse. Recycle. Save our planet.

--

REGARDS
SHYAMSUNDAR
SRI SUDHINDRA OFFSET PROCESS
MALLESWARAM 8TH CROSS
BANGALORE - 56003
CELL # 98801 33954